Josephf Odonnell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioSpace Movers & Shakers: Jeffrey Leiden, Don Hayden, Zentalis, Entera and More

Life sciences organizations and companies strengthen their leadership teams and boards with these Movers & Shakers.

United statesAnthony sunJames fosterGlympse bioEli lillyMargaret gilmourVirax biolabsSanjay zaveriTauhid aliJonathan wildeSusan howell jonesJohan baeckKimberly blackwellYair erezJosephf odonnellLefei sun

Promontory Therapeutics Appoints Johan Baeck, MD, as Executive Vice President and Chief Medical Officer

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesRegion flamandeJohan baeckRobert fallonMark corbaeStephanie carringtonJosephf odonnellTaylorb youngPromontory therapeutics incGlobal head of medical affairsPrnewswire promontory therapeutics incMerck kgaMerck kgaaAbbott laboratoriesStrategic developmentClinical development

Phosplatin Therapeutics Reports Phase 1b Study Results of Immunogenic Cell Death Inducer PT-112 Plus PD-L1 Inhibitor avelumab in Metastatic Prostate Cancer at ASCO Annual Meeting

Phosplatin Therapeutics Reports Phase 1b Study Results of Immunogenic Cell Death Inducer PT-112 Plus PD-L1 Inhibitor avelumab in Metastatic Prostate Cancer at ASCO Annual Meeting
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesAlanh bryceMark corbaeStephanie carringtonJosephf odonnellTaylorb youngPhosplatin therapeutics incMeeting libraryMerck kgaMerck kgaaPrnewswire phosplatin therapeutics incVirtual congressStrategic developmentTherapeutics incChief operatingChief medical officer

Phosplatin Therapeutics Reports Phase 1b Study Results of Immunogenic Cell Death Inducer PT-112 Plus PD-L1 Inhibitor avelumab in Metastatic Prostate Cancer at ASCO Annual Meeting